A Phase II Study of AT-101 to Overcome Bcl-2–Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer February 2016 14(1):22-27 - Subject
- Language
- ISSN
- 1558-7673